Investors

Share price

Upcoming events

Voir toutes les actualités

Conférence d’analyste / Berenberg: Pan-European Discovery Conference 2022

Résultats du 1er semestre 2022

International Oligonucleotides and Peptides Conference

 

EUROAPI profile

 

With an industrial footprint all located in Europe and thanks to a wide range of advanced technologies, EUROAPI develops, manufactures, markets and distributes APIs and intermediates used in the formulation of medicines for human and veterinary use, both from originators and generics, through its API Solutions business and CDMO activities. 

Through these activities, EUROAPI offers its customers a range of high value-added products and services to meet their commercial and regulatory needs. These customers include most of the major pharmaceutical companies, generic drug and animal health product manufacturers, consumer health and nutrition products companies, biotechnology companies and distribution companies.

EUROAPI’s strategy to further grow is focused on clear business and operational levers. We aim at accelerating our CDMO activities, expanding our differentiated presence with a particular emphasis on highly potent and complex APIs as well as tides, developing our product portfolio and realizing standalone efficiencies.

Key figures

  • 150

    years of experience in the API market

  • €902 m

    of restated revenue in 2021

  • ~200

    APIs

  • ~530

    customers in 80+ countries

  • ~330

    employees in its R&D team dedicated to industrial process development

  • ~3,350

    employees